Pfizer 2005 Annual Report Download - page 37

Download and view the complete annual report

Please find page 37 of the 2005 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

36 2005 Financial Report
Consolidated Balance Sheets
Pfizer Inc and Subsidiary Companies
AS OF DECEMBER 31,
________________________________________
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2005 2004
Assets
Current Assets
Cash and cash equivalents $2,247 $1,808
Short-term investments 19,979 18,085
Accounts receivable, less allowance for doubtful accounts: 2005—$183; 2004—$205 9,765 9,367
Short-term loans 510 653
Inventories 6,039 6,660
Prepaid expenses and taxes 3,196 2,333
Assets held for sale 160 182
Total current assets 41,896 39,088
Long-term investments and loans 2,497 3,873
Property, plant and equipment, less accumulated depreciation 17,090 18,385
Goodwill 23,774 23,756
Identifiable intangible assets, less accumulated amortization 27,786 33,251
Other assets, deferred taxes and deferred charges 4,522 4,725
Total assets $117,565 $123,078
Liabilities and Shareholders’ Equity
Current Liabilities
Short-term borrowings, including current portion of long-term debt: 2005—$778; 2004—$907 $11,589 $11,266
Accounts payable 2,226 2,672
Dividends payable 1,772 1,418
Income taxes payable 3,617 1,963
Accrued compensation and related items 1,720 1,939
Other current liabilities 7,522 7,136
Liabilities held for sale 264
Total current liabilities 28,448 26,458
Long-term debt 6,347 7,279
Pension benefit obligations 2,717 2,821
Postretirement benefit obligations 1,443 1,450
Deferred taxes 10,240 12,026
Other noncurrent liabilities 2,743 4,766
Total liabilities 51,938 54,800
Shareholders’ Equity
Preferred stock, without par value, at stated value; 27 shares authorized;
issued: 2005—4,193; 2004—4,779 169 193
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2005—8,784; 2004—8,754 439 438
Additional paid-in capital 67,622 67,098
Employee benefit trust (923) (1,229)
Treasury stock, shares at cost; 2005—1,423; 2004—1,281 (39,767) (35,992)
Retained earnings 37,608 35,492
Accumulated other comprehensive income 479 2,278
Total shareholders’ equity 65,627 68,278
Total liabilities and shareholders’ equity $117,565 $123,078
See Notes to Consolidated Financial Statements which are an integral part of these statements.